Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The over-arching aim of this study is to evaluate the effects of two specific anti-cancer chemotherapies, vincristine and doxorubicin, on bladder function and urine composition.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 5-13 lat
- •Historia choroby nowotworowej
- •Otrzymanie chemioterapii zawierającej wincystynę i/lub doksorubicynę
- •Ukończenie chemioterapii co najmniej rok przed rozpoczęciem udziału w badaniu
✗ Disqualifies
- •Nowotwór pierwotny w miednicy
- •Poprzednia radioterapia miednicy
- •Wcześniejsze problemy z pęcherzem lub jelitami
- •Wady kręgosłupa
- •Zaburzenia neurologiczne
- •Nowotwór mózgu lub przerzuty do mózgu
- •Wcześniejsza chemioterapia cyklofosfoamidu lub ifosofamidu
Simplified criteria — AI translation
Trial details
- Minimum age
- 5 Years
- Maximum age
- 13 Years
- Last updated (source)
- September 9, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Children's Hospital Colorado
Aurora, United States
Trial contact
Gemma Beltran
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/10/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.